General Information of the Compound
| Compound ID |
CP0496330
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-N-[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]-5-(diaminomethylideneamino)-2-(3,3-diphenylprop-2-enoylamino)pentanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H34N6O3
|
||||||||||||||||||
| Molecular Weight |
526.641
|
||||||||||||||||||
| Canonical SMILES |
NC(=N)NCCC[C@@H](NC(=O)C=C(c1ccccc1)c1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H34N6O3/c31-28(38)26(19-21-11-4-1-5-12-21)36-29(39)25(17-10-18-34-30(32)33)35-27(37)20-24(22-13-6-2-7-14-22)23-15-8-3-9-16-23/h1-9,11-16,20,25-26H,10,17-19H2,(H2,31,38)(H,35,37)(H,36,39)(H4,32,33,34)/t25-,26-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DHTFKWGWZOSSLT-CLJLJLNGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT04406, Neuropeptide FF receptor 1
Protein ID: PT02666, Neuropeptide FF receptor 2
Protein ID: PT01360, Nociceptin receptor
Protein ID: PT07717, Prolactin-releasing peptide
Protein ID: PT05331, Pyroglutamylated RF-amide peptide receptor